仙琚制药(002332) - 2018 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2018 was ¥829,940,103.40, representing a 46.62% increase compared to ¥566,045,579.77 in the same period last year[8]. - Net profit attributable to shareholders was ¥40,501,223.77, a significant increase of 149.45% from ¥16,235,968.85 year-on-year[8]. - The net profit after deducting non-recurring gains and losses was ¥41,019,589.09, reflecting a 160.23% increase compared to ¥15,762,982.28 in the previous year[8]. - The basic earnings per share rose to ¥0.04, doubling from ¥0.02 in the same quarter last year[8]. - Operating revenue increased by 46.62% year-on-year, an increase of 263.89 million yuan, primarily due to increased sales and mergers with non-similar controlled enterprises[15]. - The net profit attributable to shareholders of the listed company for the first half of 2018 is expected to increase by 30.00% to 60.00%, ranging from 105.52 million to 129.87 million yuan[18]. Assets and Shareholder Information - The total assets at the end of the reporting period were ¥5,264,388,752.81, up 2.53% from ¥5,134,599,095.24 at the end of the previous year[8]. - The net assets attributable to shareholders increased to ¥2,393,754,824.19, a rise of 1.72% from ¥2,353,267,776.36 at the end of the last year[8]. - The company reported a total of 28,318 common shareholders at the end of the reporting period[11]. - The largest shareholder, Xianju County State-owned Assets Investment Group Co., Ltd., held 21.55% of the shares, totaling 197,488,304 shares[11]. Cash Flow and Expenses - The net cash flow from operating activities was negative at -¥126,233,633.02, worsening by 99.22% compared to -¥63,365,266.39 in the same period last year[8]. - Cash received from sales of goods and services increased by 59.71% year-on-year, an increase of 292.49 million yuan, attributed to increased sales and mergers with non-similar controlled enterprises[16]. - Cash paid for operating activities increased by 110.58% year-on-year, an increase of 207.47 million yuan, mainly due to increased deposits[16]. - Financial expenses increased by 205.36% year-on-year, an increase of 17.24 million yuan, mainly due to mergers with non-similar controlled enterprises and increased borrowing interest expenses[15]. - Tax expenses increased by 1031.26% year-on-year, an increase of 18.98 million yuan, mainly due to the increase in total profit[15]. Accounts and Investments - Accounts receivable increased by 34.39% compared to the beginning of the year, an increase of 210.58 million yuan, mainly due to total sales exceeding cash collection[15]. - Prepayments increased by 83.96% compared to the beginning of the year, an increase of 27.50 million yuan, mainly due to increased prepayments as per contracts[15]. - Investment income increased by 202.26% year-on-year, an increase of 4.45 million yuan, mainly due to increased profits from affiliated companies[15]. Business Outlook - The company expects to maintain steady growth in its main business segments, including formulations and raw materials, contributing to overall performance improvement[18].